Adrian Senderowicz Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adrian Senderowicz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adrian Senderowicz. Adrian Senderowicz is SVP, Chief Medical Officer in Cerulean Pharma Inc. ($CERU) and Director in PUMA BIOTECHNOLOGY, INC. ($PBYI) and Chief Medical Officer in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Chief Medical Officer in Ignyta, Inc. ($RXDX).
Latest Insider Trading Transactions of Adrian Senderowicz
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CNST, DARE, RXDX, PBYI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2020 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Sell | S | 9.89 | 10,000 | 98,878 | 40,993 | 51 K to 41 K (-19.61 %) |
Jun 11 2020 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Grant | A | 0.00 | 25,748 | 0 | 50,993 | 25.2 K to 51 K (+101.99 %) |
May 13 2020 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Option Exercise | M | 5.51 | 9,357 | 51,557 | 99,663 | |
May 13 2020 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Sell | S | 50.18 | 9,357 | 469,488 | 15,884 | 25.2 K to 15.9 K (-37.07 %) |
May 13 2020 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Buy | M | 5.51 | 9,357 | 51,557 | 25,241 | 15.9 K to 25.2 K (+58.91 %) |
Nov 08 2019 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Option Exercise | M | 5.51 | 27,232 | 150,048 | 109,020 | |
Nov 08 2019 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Sell | S | 35.11 | 5,451 | 191,394 | 15,884 | 21.3 K to 15.9 K (-25.55 %) |
Nov 08 2019 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Sell | S | 30.14 | 10,899 | 328,536 | 21,335 | 32.2 K to 21.3 K (-33.81 %) |
Nov 08 2019 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Sell | S | 25.18 | 5,451 | 137,256 | 32,234 | 37.7 K to 32.2 K (-14.46 %) |
Nov 08 2019 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Sell | S | 20.01 | 5,431 | 108,662 | 37,685 | 43.1 K to 37.7 K (-12.60 %) |
Nov 08 2019 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Buy | M | 5.51 | 27,232 | 150,048 | 43,116 | 15.9 K to 43.1 K (+171.44 %) |
Jun 12 2019 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Grant | A | 0.00 | 19,423 | 0 | 25,245 | 5.8 K to 25.2 K (+333.61 %) |
Mar 08 2019 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Option Exercise | A | 8.76 | 93,000 | 814,680 | 93,000 | |
Dec 17 2018 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Option Exercise | M | 5.51 | 6,801 | 37,474 | 65,866 | |
Dec 17 2018 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Option Exercise | M | 5.51 | 9,083 | 50,047 | 136,252 | |
Dec 17 2018 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Buy | M | 5.51 | 6,801 | 37,474 | 15,884 | 9.1 K to 15.9 K (+74.88 %) |
Dec 17 2018 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Buy | M | 5.51 | 9,083 | 50,047 | 9,083 | 0 to 9.1 K |
Jul 20 2018 | CNST | CONSTELLATION PHAR ... | Senderowicz Adrian | Chief Medical Offic ... | Option Exercise | A | 11.50 | 19,075 | 219,363 | 19,075 | |
Jun 14 2018 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Grant | A | 0.00 | 5,822 | 0 | 5,822 | 0 to 5.8 K |
Jun 14 2017 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Option Exercise | A | 79.20 | 7,604 | 602,237 | 7,604 | |
Jan 09 2017 | CERU | Cerulean Pharma In ... | Senderowicz Adrian | SVP, Chief Medical ... | Option Exercise | A | 0.82 | 150,000 | 123,000 | 150,000 | |
Jan 09 2017 | CERU | Cerulean Pharma In ... | Senderowicz Adrian | SVP, Chief Medical ... | Option Exercise | A | 0.82 | 60,000 | 49,200 | 60,000 | |
Nov 16 2016 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Option Exercise | A | 40.10 | 10,000 | 401,000 | 10,000 | |
Aug 23 2016 | CERU | Cerulean Pharma In ... | Senderowicz Adrian | SVP, Chief Medical ... | Option Exercise | A | 1.14 | 100,000 | 114,000 | 100,000 | |
Apr 15 2016 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Option Exercise | A | 31.95 | 10,000 | 319,500 | 10,000 | |
Jan 07 2016 | CERU | Cerulean Pharma In ... | Senderowicz Adrian | SVP, Chief Medical ... | Option Exercise | A | 3.04 | 50,000 | 152,000 | 50,000 | |
Dec 17 2015 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Option Exercise | A | 75.37 | 10,000 | 753,700 | 10,000 | |
Dec 03 2015 | CERU | Cerulean Pharma In ... | Senderowicz Adrian | SVP, Chief Medical ... | Option Exercise | A | 3.29 | 158,000 | 519,820 | 158,000 | |
Dec 03 2015 | CERU | Cerulean Pharma In ... | Senderowicz Adrian | SVP, Chief Medical ... | Option Exercise | A | 4.21 | 135,000 | 568,350 | 135,000 | |
Sep 10 2015 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Option Exercise | A | 95.22 | 10,000 | 952,200 | 10,000 | |
Aug 13 2015 | PBYI | PUMA BIOTECHNOLOGY ... | Senderowicz Adrian | Director | Option Exercise | A | 97.01 | 30,000 | 2,910,300 | 30,000 | |
Jan 09 2015 | RXDX | Ignyta, Inc. | Senderowicz Adrian | Chief Medical Offic ... | Option Exercise | A | 6.58 | 8,400 | 55,272 | 8,400 | |
Aug 11 2014 | RXDX | Ignyta, Inc. | Senderowicz Adrian | Chief Medical Offic ... | Option Exercise | A | 7.59 | 250,000 | 1,897,500 | 250,000 |
Page: 1